Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.; Raises Target Price to $4.50
06 nov. 2012 09h15 HE
|
Vista Partners LLC
SAN FRANCISCO, CA--(Marketwire - Nov 6, 2012) - Vista Partners announced today that it has updated coverage on ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) ("ADVENTRX" or "ANX"); and raised its...